On December 15, 2020, Genentech led a discussion about how the Most Favored Nations (MFN) model threatens provider and patient access to existing and future medicines; we share your concerns that this could have a detrimental impact on your practice
Downloadable Resources from the Arthritis Foundation
The Arthritis Foundation has free downloadable brochures and fact sheets through the AF Store that you can save to your office desktop. The brochures and fact sheets can be e-mailed to patients or you can print copies in-office and hand
Biosimilars Could Generate $100 Billion in Savings Over Next Five Years, New Report Finds
WASHINGTON, D.C. — A new report from the IQVIA Institute for Human Data Science has determined that biosimilars are on track to reduce drug costs by $100 billion over the next five years if their use rises. The future of this lower-cost
Coronavirus: What Chronic Illness Patients Need to Know
From CreakyJoints: We’ve been hearing many questions and concerns from our global patient community about the continued spread of coronavirus across the U.S. and around the world. And while people with disabilities and chronic diseases have even more of a
Regence Rituxan to Ruxience has been Reversed
Regence Policy Reversed: The decision from Regence to mandate the switch from Rituxan patients to Ruxience has been reversed and Regence will approve Rituxan patients currently on treatment to continue for 1 year. If you have already submitted the authorization
Interstitial lung disease exacerbates rheumatoid arthritis activity, related conditions
Patients with interstitial lung disease demonstrated a higher proportion of comorbidities and rheumatoid arthritis activity, as well as rheumatoid arthritis-related conditions, according to a presenter at the EULAR 2020 Virtual Congress. “Interstitial lung disease is a common extra-articular manifestation of
COVID-19 Prior Authorization and Ongoing Patient Care Updates from UnitedHealth
UnitedHealthcare is working to help people access health care to the fullest extent possible as we come together to address this national emergency. We’re adopting measures that will reduce administrative burden for physicians and facilities, helping members more easily access
UnitedHealth Group Accelerates Nearly $2 Billion in Payments and Support to Health Care Providers to Help with COVID-19 Financial Challenges
Please see the formal announcement from UHC. UnitedHealth Group (NYSE: UNH), through UnitedHealthcare and Optum, has announced it is taking steps immediately to accelerate payments and other financial support to health care providers in the U.S. to help address the
MED limit removed from HCA opioid policy
August 23, 2017 Update to new HCA opioid policy: On August 23, 2017, the Health Care Authority sent a message through GovDelivery to providers explaining the new HCA opioid policy, which will go into effect for Medicaid on October 1,
New opioid clinical policy (effective October 1, 2017)
Washington State Healthcare Authority Announcement: Healthcare providers should be aware that on October 1, 2017, a new Washington State Health Care Authority (HCA) clinical policy pertaining to opioid prescriptions takes effect for Apple Health (Medicaid), both through managed care organizations